A phase III, double-blind, randomized, active controlled study to evaluate the safety and consistency of immunogenicity of three consecutive lots of a Meningococcal A Conjugate Vaccine administered as a single dose to healthy children at 5-10 years of age.

Trial Profile

A phase III, double-blind, randomized, active controlled study to evaluate the safety and consistency of immunogenicity of three consecutive lots of a Meningococcal A Conjugate Vaccine administered as a single dose to healthy children at 5-10 years of age.

Completed
Phase of Trial: Phase III

Latest Information Update: 27 Aug 2016

At a glance

  • Drugs Meningococcal vaccine group A conjugate; Meningococcal vaccine groups A and C polysaccharide
  • Indications Meningococcal group A infections; Meningococcal group C infections
  • Focus Adverse reactions; Pharmacodynamics
  • Sponsors Serum Institute of India
  • Most Recent Events

    • 16 Jan 2011 Status changed from active, no longer recruiting to completed as reported by Clinical Trials Registry - India.
    • 07 Aug 2010 Status changed from recruiting to active, no longer recruiting as reported by Clinical Trials Registry - India record.
    • 06 Mar 2010 Status changed from not yet recruiting to recruiting as reported by Clinical Trials Registry - India.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top